Pre-Conference Symposia

Pre-Conference Symposia

Protective Effects of Insulin and Incretins in AD/PD

Tuesday, March 9, 2021
14:00 – 19:00
Registration required

Session Chair: Christian Hölscher

Time

Name

Country

Lecture Title

13:50 -14:00Christian HölscherChinaWeclome and Introduction
14:00-14:20Suzanne CraftUSAIntranasal insulin as a therapy for Alzheimer’s disease
14:20-14:40Tom FoltynieUKClinical trial of Bydureon (exenatide) in PD patients
14:40-15:00Paul EdisonUKClinical trial of liraglutide in AD patients
15:00-15:20Michele TagliatiUSAClinical trial of liraglutide in PD patients
15:20-15:40Wassilios MeissnerFranceClinical trial of lixisenatide in PD patients, insulin receptors in post-mortem brain tissue of PD patients
15:40-16:00Dimitrios KapogiannisUSAInsulin signaling biomarkers in blood exosomes of AD and PD patients
16:00-16:20Coffee Break
16:20-16:40Konrad TalbotUSADirect demonstration of brain insulin resistance in Alzheimer’s and Parkinson’s disease dementia and its alleviation with incretin receptor agonists
16:40-17:00William BanksUSARoles of the blood-brain barrier in neurodegenerative diseases
17:00-17:10Fernanda G. De FeliceBrazilDefective hormonal signalling in Alzheimer’s disease.
17:10 -17:20Sergio T. FerreiraBrazilDefective hormonal signalling in Alzheimer’s disease.
17:20-17:40Nigel GreigUSAProtective peptide hormone signalling in AD and traumatic brain injury
17:40-18:00Ana Isabel DuartePortugalThe neuroprotective effects of insulin/IGF-1/GLP-1 signalling recovery in type 2 diabetes and neurodegenerative diseases
18:00-18:20Christian HölscherChinaNovel dual GLP-1/GIP receptor agonists and are superior to single receptor agonists in animal models of Alzheimer and Parkinson’s disease
18:20-18:55AllRound Table Dicussion
18:55 – 19:00Christian HölscherClosing Remarks